Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes.
Jan KralMarek BenesVera LanskaPeter MacingaPavel DrastichJulius SpicakTomas HuclPublished in: Obesity surgery (2023)
Despite an evident rate of adverse events, the DJB shows promise as a weight-loss procedure. Our results show that some patients implanted with the device maintained reduced weight even 24 months after explantation, while many improved T2DM control.
Keyphrases
- weight loss
- type diabetes
- bariatric surgery
- end stage renal disease
- glycemic control
- insulin resistance
- weight gain
- ejection fraction
- chronic kidney disease
- roux en y gastric bypass
- newly diagnosed
- metabolic syndrome
- physical activity
- cardiovascular disease
- body mass index
- patient reported outcomes
- big data
- combination therapy
- artificial intelligence
- body weight